No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113629200-113643200 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr2:113632800-113644400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
3 |
chr2:113637000-113643600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
4 |
chr2:113639200-113644400 |
Enhancers |
NHEK |
skin
|
5 |
chr2:113639200-113647800 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
6 |
chr2:113639600-113645400 |
Weak transcription |
Primary neutrophils fromperipheralblood |
blood
|
7 |
chr2:113640000-113642600 |
Weak transcription |
Osteobl |
bone
|
8 |
chr2:113640400-113645400 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
9 |
chr2:113640400-113647800 |
Weak transcription |
Brain Inferior Temporal Lobe |
brain
|
10 |
chr2:113641600-113642800 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
11 |
chr2:113642200-113642600 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
12 |
chr2:113642200-113642600 |
Enhancers |
ES-WA7 Cell Line |
embryonic stem cell
|
13 |
chr2:113642200-113642600 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
14 |
chr2:113642200-113642600 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
15 |
chr2:113642200-113642600 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
16 |
chr2:113642200-113642600 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
17 |
chr2:113642200-113642600 |
Enhancers |
Liver |
Liver
|
18 |
chr2:113642200-113642600 |
Enhancers |
Stomach Mucosa |
stomach
|
19 |
chr2:113642200-113642800 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
20 |
chr2:113642200-113642800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
21 |
chr2:113642200-113643000 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
22 |
chr2:113642200-113643200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
23 |
chr2:113642200-113643200 |
Enhancers |
Primary T helper naive cells from peripheral blood |
blood
|
24 |
chr2:113642200-113643200 |
Enhancers |
Colon Smooth Muscle |
Colon
|
25 |
chr2:113642200-113643200 |
Enhancers |
GM12878-XiMat |
blood
|
26 |
chr2:113642200-113643200 |
Enhancers |
Hela-S3 |
cervix
|
27 |
chr2:113642200-113643600 |
Enhancers |
HMEC |
breast
|
28 |
chr2:113642400-113642600 |
Enhancers |
Brain Hippocampus Middle |
brain
|
29 |
chr2:113642400-113642800 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
30 |
chr2:113642400-113642800 |
Enhancers |
Primary T regulatory cells fromperipheralblood |
blood
|
31 |
chr2:113642400-113642800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
32 |
chr2:113642400-113643000 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
33 |
chr2:113642400-113643200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
34 |
chr2:113642400-113643200 |
Enhancers |
Primary T cells fromperipheralblood |
blood
|
35 |
chr2:113642400-113643200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
36 |
chr2:113642400-113643200 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
37 |
chr2:113642400-113643200 |
Enhancers |
Primary T helper cells fromperipheralblood |
blood
|
38 |
chr2:113642400-113643200 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
39 |
chr2:113642400-113643200 |
Enhancers |
Fetal Thymus |
thymus
|
40 |
chr2:113642400-113643200 |
Enhancers |
K562 |
blood
|
41 |
chr2:113642400-113643400 |
Enhancers |
HepG2 |
liver
|
42 |
chr2:113642400-113643400 |
Enhancers |
NHDF-Ad |
bronchial
|